相关实验视频

Updated: Jun 7, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K

在接受PD-1和PD-L1抑制剂治疗的癌症患者中诱导皮肤不良反应的因素:机器学习算法方法

Young-Ah Cho1, Youngyun Moon2, Wooyoung Park2

  • 1The Prime Hospital, Jinju, Gyeongsangnam-do, Republic of Korea.

Immunopharmacology and immunotoxicology
|November 14, 2024
PubMed
概括

这项研究发现,抗组胺使用和癌症转移与免疫检查点抑制剂 (ICI) 的皮肤反应增加有关. 糖尿病和阿片类药物使用与较少的皮肤问题有关,有助于个性化ICI治疗策略.

关键词:
免疫检查点抑制剂 免疫检查点抑制剂皮肤的不良事件.机器学习是机器学习.有关风险因素的风险因素.皮肤不良事件不良事件

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K